Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Nemaline myopathy 1 - (AD) | 3.1 | | |  | * Nemaline myopathy 1, autosomal dominant - NEM1 |
|
Nemaline myopathy 2 - (AR) | 3.2 | | | | * Distal myopathy with nebulin defect |  | * Nemaline myopathy 2, autosomal recessive - NEM2 |
|
Nemaline myopathy 3 - (AD, AR) | 3.3 | | | Alpha actin, skeletal muscle
|
|
|  | * myopathy, congenital, with fiber-type disproportion - CFTD | | * Congenital muscular dystrophy with rigid spine related to ACTA1 |  | * Left ventricular noncompaction 4 - LVNC4 |  | * Nemaline myopathy 3 - NEM3 |
|
Nemaline myopathy 4 - (AD) | 3.4 | | |  | * Arthrogryposis, distal, type 1A - DA1A |  | * arthrogryposis, distal, type 2B - DA2B |  | * Cap myopathy, TPM2-related, included |  | * Nemaline myopathy 4 - NEM4 |
|
Nemaline myopathy 5 - (AR) | 3.5 | | |  | * Nemaline myopathy 5 - NEM5 |
|
Nemaline myopathy 6 - (AD) | 3.6 | | | Kelch repeat and BTB (POZ) domain containing 13
|
|
|  | * Nemaline myopathy 6 - NEM6 | | * LGMD related to KBTBD13 |
|
Nemaline myopathy 7 - (AR) | 3.7 | | |  | * Nemaline myopathy - NEM7 |
|
Nemaline myopathy 8 - (AR) | 3.8 | | | Kelch-like family member 40
|
|
|  | * Severe autosomal-recessive nemaline myopathy - NEM8 |
|
Nemaline myopathy 9 - (AR) | 3.9 | | | Kelch-like family member 41
|
|
|  | * Nemaline myopathy - NEM9 |
|
Nemaline myopathy 10 - (AR) | 3.10 | | |  | * Nemaline myopathy - NEM10 |
|
Nemaline myopathy 11 - (AE) | 3.11 | | |  | * Hypertrophic cardiomyopathy related to cardiac myopalladin - CMH22 |  | * Nemaline myopathy - NEM11 |
|
Klippel-Feil syndrome with Nemalin myopathy and facial dysmorphism - (AR) | 3.12 | | | | * Nemaline Myopathy with
Cardiomyopathy |  | * Klippel-Feil syndrome with Nemalin myopathy and facial dysmorphism - KFS4 |
|
Myopathy with nemaline bodies - (AR) | 3.13 | | | | * Myopathy with nemaline bodies |
|
Nemalin myopathy with distal arthrogryposis - (AR) | 3.14 | | |  | * Arthrogryposis, distal, type 2B - DA2B | | * Nemalin myopathy with distal arthrogryposis |
|
Myopathy, congenital, with fiber-type disproportion 1 - (AD) | 3.15 | | | Alpha actin, skeletal muscle
|
|
|  | * myopathy, congenital, with fiber-type disproportion - CFTD | | * Congenital muscular dystrophy with rigid spine related to ACTA1 |  | * Left ventricular noncompaction 4 - LVNC4 |  | * Nemaline myopathy 3 - NEM3 |
|
Myopathy, congenital, with fiber-type disproportion - (AR) | 3.16 | | |  | * Multiminicore disease, classical form |  | * myopathy, congenital, with fiber-type disproportion - CFTD | | * Rigid spine syndrome related to SEPN1 - RSS |  | * Rigid spine syndrome - RSMD1 |  | * Muscular dystrophy, rigid spine, 1 - RSMD1 |  | * Desmin-related myopathy with Mallory bodies - RSMD1 |
|
Myopathy congenital, with fiber-type disproportion - (AR) | 3.17 | | |  | * Nemaline myopathy 1, autosomal dominant - NEM1 |
|
Myopathy, congenital, with fiber-type disproportion - (AR) | 3.18 | | | Ryanodine receptor 1 (skeletal)
|
|
|  | * centronuclear myopathy, recessive |  | * minicore myopathy with external ophthalmoplegia | | * myopathy, congenital, with fiber-type disproportion - CFTD | | * Fetal akinesia deformation sequence related to RYR1 |  | * Dusty core disease related to RYR1 - DuCD |  | * Malignant hyperthermia susceptibility 1 - MHS1 |  | * Central core disease - CCD |
|
Myopathy, congenital, with fiber-type disproportion - (AD) | 3.19 | | | Myosin, heavy polypeptide 7, cardiac muscle, beta
|
|
|  | * Cardiomyopathy, dilated, 1S - CMD1S |  | * Myopathy, distal 1 - MPD1 |  | * cardiomyopathy, familial hypertrophic, 1, included - CMH1 |  | * Left ventricular noncompaction 5 - LVNC5 |  | * Myopathy, myosin storage, autosomal dominant - MSMB |  | * Myosin storage myopathy |
|
Myopathy congenital, with fiber-type disproportion - (AR) | 3.20 | | |  | * myopathy, congenital, with fiber-type disproportion - CFTD |  | * Cardiomyopathy, familial hypertrophic, 10 - CMH10 |  | * Cardiomyopathy, hypertrophic, 10 - CMH10 |
|
Myopathy, congenital, with fiber-type disproportion - (AR) | 3.21 | | | Mitogen-activated protein kinase kinase 20
|
|
|  | * Centronuclear myopathy 6 with fiber-type disproportion - CNM6 |
|
Myotubular myopathy, X-linked - (XR) | 3.22 | | |  | * Myotubular myopathy, X-linked - MTM1 |
|
Centronuclear myopathy 1 - (AD) | 3.23 | | |  | * Charcot-Marie-Tooth disease, dominant intermediate B - CMTDIB |  | * Myopathy centronuclear, 1 - CNM1 |  | * Lethal Congenital Contracture Syndrome 5 - LCCS5 |
|
Centronuclear myopathy 2 - (AD) | 3.24 | | |  | * Centronuclear myopathy 2 - CNM2 |
|
Centronuclear myopathy 4 - (AD) | 3.25 | | | Coiled-coil domain-containing protein 78
|
|
|  | * Centronuclear myopathy 4 - CNM4 |
|
Centronuclear myopathy 5 - (AR) | 3.26 | | |  | * Centronuclear myopathy 5 - CNM5 |
|
Centronuclear myopathy related to RYR1 - (AR) | 3.27 | | | Ryanodine receptor 1 (skeletal)
|
|
|  | * centronuclear myopathy, recessive |  | * minicore myopathy with external ophthalmoplegia | | * myopathy, congenital, with fiber-type disproportion - CFTD | | * Fetal akinesia deformation sequence related to RYR1 |  | * Dusty core disease related to RYR1 - DuCD |  | * Malignant hyperthermia susceptibility 1 - MHS1 |  | * Central core disease - CCD |
|
Centronuclear myopathy (CNM) related to TTN - (AD) | 3.28 | | |  | * Hereditary myopathy with early respiratory failure - HMERF |  | * Cardiomyopathy, familial hypertrophic, 9 - CMH9 | | * Congenital myopathy with fatal cardiomyopathy |  | * Cardiomyopathy, dilated, 1G - CMD1G | | * Centronuclear myopathy related to TTN | | * LGMDR10 (Formerly LGMD2J) | | * Lethal Congenital Contracture Syndrome related to TTN |  | * Autosomal dominant myopathy with proximal muscle weakness and early respiratory |  | * Tibial muscular dystrophy, tardive - TMD |  | * Limb girdle muscular dystrophy 2J (autosomal recessive) - LGMD2J |
|
Central core disease, dominant - (AD) | 3.29 | | | Ryanodine receptor 1 (skeletal)
|
|
|  | * centronuclear myopathy, recessive |  | * minicore myopathy with external ophthalmoplegia | | * myopathy, congenital, with fiber-type disproportion - CFTD | | * Fetal akinesia deformation sequence related to RYR1 |  | * Dusty core disease related to RYR1 - DuCD |  | * Malignant hyperthermia susceptibility 1 - MHS1 |  | * Central core disease - CCD |
|
Central core disease, recessive (transient multiminicore myopathy) - (AR) | 3.30 | | | Ryanodine receptor 1 (skeletal)
|
|
|  | * centronuclear myopathy, recessive |  | * minicore myopathy with external ophthalmoplegia | | * myopathy, congenital, with fiber-type disproportion - CFTD | | * Fetal akinesia deformation sequence related to RYR1 |  | * Dusty core disease related to RYR1 - DuCD |  | * Malignant hyperthermia susceptibility 1 - MHS1 |  | * Central core disease - CCD |
|
Multiminicore disease with external ophtalmopegia - (AR) | 3.31 | | | Ryanodine receptor 1 (skeletal)
|
|
|  | * centronuclear myopathy, recessive |  | * minicore myopathy with external ophthalmoplegia | | * myopathy, congenital, with fiber-type disproportion - CFTD | | * Fetal akinesia deformation sequence related to RYR1 |  | * Dusty core disease related to RYR1 - DuCD |  | * Malignant hyperthermia susceptibility 1 - MHS1 |  | * Central core disease - CCD |
|
Multiminicore disease (MmD), classical form - (AR) | 3.32 | | |  | * Multiminicore disease, classical form |  | * myopathy, congenital, with fiber-type disproportion - CFTD | | * Rigid spine syndrome related to SEPN1 - RSS |  | * Rigid spine syndrome - RSMD1 |  | * Muscular dystrophy, rigid spine, 1 - RSMD1 |  | * Desmin-related myopathy with Mallory bodies - RSMD1 |
|
Multiminicore disease (MmD) related to TTN - (AR) | 3.33 | | |  | * Hereditary myopathy with early respiratory failure - HMERF |  | * Cardiomyopathy, familial hypertrophic, 9 - CMH9 | | * Congenital myopathy with fatal cardiomyopathy |  | * Cardiomyopathy, dilated, 1G - CMD1G | | * Centronuclear myopathy related to TTN | | * LGMDR10 (Formerly LGMD2J) | | * Lethal Congenital Contracture Syndrome related to TTN |  | * Autosomal dominant myopathy with proximal muscle weakness and early respiratory |  | * Tibial muscular dystrophy, tardive - TMD |  | * Limb girdle muscular dystrophy 2J (autosomal recessive) - LGMD2J |
|
Early onset myopathy, areflexia, respiratory distress and dysphagia - (AR) | 3.34 | | | Multiple EGF-like-domains 10
|
|
| | * Recessive congenital myopathy with minicores |  | * Early onset myopathy, areflexia, respiratory distress and dysphagia - EMARDD |
|
Recessive congenital myopathy with minicores - (AR) | 3.35 | | | Multiple EGF-like-domains 10
|
|
| | * Recessive congenital myopathy with minicores |  | * Early onset myopathy, areflexia, respiratory distress and dysphagia - EMARDD |
|
Myopathy, myosin storage, autosomal dominant - (AD) | 3.36 | | | Myosin, heavy polypeptide 7, cardiac muscle, beta
|
|
|  | * Cardiomyopathy, dilated, 1S - CMD1S |  | * Myopathy, distal 1 - MPD1 |  | * cardiomyopathy, familial hypertrophic, 1, included - CMH1 |  | * Left ventricular noncompaction 5 - LVNC5 |  | * Myopathy, myosin storage, autosomal dominant - MSMB |  | * Myosin storage myopathy |
|
Myopathy, myosin storage, autosomal dominant (eccentric core disease) - (AD) | 3.37 | | | Myosin, heavy polypeptide 7, cardiac muscle, beta
|
|
|  | * Cardiomyopathy, dilated, 1S - CMD1S |  | * Myopathy, distal 1 - MPD1 |  | * cardiomyopathy, familial hypertrophic, 1, included - CMH1 |  | * Left ventricular noncompaction 5 - LVNC5 |  | * Myopathy, myosin storage, autosomal dominant - MSMB |  | * Myosin storage myopathy |
|
Myopathy, myosin storage, autosomal recessive - (AR) | 3.38 | | | Myosin, heavy polypeptide 7, cardiac muscle, beta
|
|
|  | * Cardiomyopathy, dilated, 1S - CMD1S |  | * Myopathy, distal 1 - MPD1 |  | * cardiomyopathy, familial hypertrophic, 1, included - CMH1 |  | * Left ventricular noncompaction 5 - LVNC5 |  | * Myopathy, myosin storage, autosomal dominant - MSMB |  | * Myosin storage myopathy |
|
Myopathy proximal to ophthalmoplegia, recessive (Inclusion body myopathy 3) - (AD/AR) | 3.39 | | | Myosin, heavy polypeptide 2, skeletal muscle
|
|
|  | * Myopathy congenital, with fiber-type disproportion - CFTD |  | * Myopathy proximal to ophthalmoplegia, recessive (Inclusion body myopathy 3) - MYPOP |  | * Myopathy with joint contractures, ophtalmoplegia, and rimmed vacuoles - IBM3 |
|
Isolated inclusion body myopathy - (AD) | 3.40 | | | Heterogeneous nuclear ribonucleoprotein A1
|
|
|  | * Isolated inclusion body myopathy - IBMPFD3 |  | * Amyotrophic lateral sclerosis 20 - ALS20 |
|
Cap myopathy CAPM1 - (AD, AR) | 3.41 | | |  | * Nemaline myopathy 1, autosomal dominant - NEM1 |
|
Cap myopathy CAPM2 - (AD) | 3.42 | | |  | * Arthrogryposis, distal, type 1A - DA1A |  | * arthrogryposis, distal, type 2B - DA2B |  | * Cap myopathy, TPM2-related, included |  | * Nemaline myopathy 4 - NEM4 |
|
Cap myopathy - (AD) | 3.43 | | | Alpha actin, skeletal muscle
|
|
|  | * myopathy, congenital, with fiber-type disproportion - CFTD | | * Congenital muscular dystrophy with rigid spine related to ACTA1 |  | * Left ventricular noncompaction 4 - LVNC4 |  | * Nemaline myopathy 3 - NEM3 |
|
Congenital neuromuscular disease with uniform type 1 fiber (CNMDU1) - (AR, AD) | 3.44 | | | Ryanodine receptor 1 (skeletal)
|
|
|  | * centronuclear myopathy, recessive |  | * minicore myopathy with external ophthalmoplegia | | * myopathy, congenital, with fiber-type disproportion - CFTD | | * Fetal akinesia deformation sequence related to RYR1 |  | * Dusty core disease related to RYR1 - DuCD |  | * Malignant hyperthermia susceptibility 1 - MHS1 |  | * Central core disease - CCD |
|
Salih myopathy, (Congenital myopathy with fatal cardiomyopathy) - (AR) | 3.45 | | |  | * Hereditary myopathy with early respiratory failure - HMERF |  | * Cardiomyopathy, familial hypertrophic, 9 - CMH9 | | * Congenital myopathy with fatal cardiomyopathy |  | * Cardiomyopathy, dilated, 1G - CMD1G | | * Centronuclear myopathy related to TTN | | * LGMDR10 (Formerly LGMD2J) | | * Lethal Congenital Contracture Syndrome related to TTN |  | * Autosomal dominant myopathy with proximal muscle weakness and early respiratory |  | * Tibial muscular dystrophy, tardive - TMD |  | * Limb girdle muscular dystrophy 2J (autosomal recessive) - LGMD2J |
|
Congenital skeletal myopathy and fatal cardiomyopathy - (AR) | 3.46 | | | Cardiac myosin binding protein-C
|
|
|  | * Cardimyopathy, dilated, 1A - CMD1A | | * Dilated cardiomyopathy related to MYBPC3 | | * congenital skeletal myopathy and fatal cardiomyopathy |  | * Left ventricular noncompaction 10 - LVNC10 |  | * Cardiomyopathy, familial hypertrophic, 4 - CMH4 |
|
Congenital myopathy Compton-North - (AR) | 3.47 | | |  | * Congenital myopathy Compton-North |
|
Sarcotubular myopathy - (AR) | 3.48 | | | Tripartite motif-containing 32
|
|
| | * Sarcotubular myopathy |  | * Muscular dystrophy, limb-girdle, type 2H - LGMD2H |
|
Congenital myopathy related to HACD1 - (AR) | 3.49 | | | Protein tyrosine phosphatase-like (3-Hydroxyacyl-CoA dehydratase
|
|
|  | * Arrhythmogenic right ventricular cardiomyopathy 6 - ARVC6 |  | * Arrhythmogenic right ventricular dysplasia, familial, 6 - ARVD6 | | * Congenital myopathy related to PTPLA |
|
Congenital myopathy with ophthalmoplegia related to CACNA1S - (AR) | 3.50 | | | Calcium channel, voltage-dependent, L type, alpha 1S subunit
|
|
|  | * Hypokalemic periodic paralysis - CACNL1A3 | | * Congenital myopathy with ophthalmoplegia related to CACNA1S |  | * Malignant hyperthermia susceptibility 5 - MHS5 |  | * Hypokalaemic periodic paralysis, type 1 - hypoKPP1 |
|
Myopathy, Congenital, With Neuropathy And Deafness - (AR) | 3.51 | | | Spectrin, Beta, Nonerythrocytic, 4
|
|
|  | * Myopathy, Congenital, With Neuropathy And Deafness - CMND |
|
Myopathy, congenital, With excess of muscle spindles - (AD) | 3.52 | | | V-Ha-RAS Harvey Rat Sarcoma Viral
|
|
|  | * Myopathy, congenital, With excess of muscle spindles - CMEMS |
|
Carey-Fineman-Ziter syndrome (formerly congenital myopathy with Moebius sequence and Robin sequence) - (AR) | 3.53 | | |  | * Carey-Fineman-Ziter syndrome (formerly congenital myopathy with Moebius sequence and Robin sequence) - CFZS |
|
Myopathy, congenital, Baily-Bloch (Native American myopathy) - (AR) | 3.54 | | | SH3 and cysteine rich domain 3
|
|
|  | * Myopathy, congenital, Bailey-Bloh - MYPBB | | * Myopathy, congenital, with malignant hyperthermia susceptibility |
|
Myopathy, congenital, with malignant hyperthermia susceptibility - (AR) | 3.55 | | | SH3 and cysteine rich domain 3
|
|
|  | * Myopathy, congenital, Bailey-Bloh - MYPBB | | * Myopathy, congenital, with malignant hyperthermia susceptibility |
|
Myopathy congenital with structured cores and Z-line abnormalities - (AD) | 3.56 | | | | * Hypertrophic cardiomyopathy related to actinin-2 |  | * dilated cardiomyopathy, 1aa - CMD1AA |  | * Myopathy, distal 6, Adult-onset - MPD6 |
|
Myopathy congenital with fast twitch (type II) fiber atrophy - (AR) | 3.57 | | | Myosin, light polypeptide 1, alkali, skeletal fast
|
|
|  | * Myopathy congenital with fast twitch (type II) fiber atrophy - MYOFTA |
|
Congenital amyotrophy - (AR) | 3.58 | | | Calcium channel, voltage-dependent, T type, aplpha-1H subunit
|
|
| |
Myopathy, congenital proximal with minicore lesions - (AR) | 3.59 | | |  | * Myopathy, congenital proximal with minicore lesions - MYOPMIL |  | * Myopathy, congenital with respitory insufficiency and bone fractures - MYORIBF |
|
Myopathy, congenital with respitory insufficiency and bone fractures - (AR) | 3.60 | | |  | * Myopathy, congenital proximal with minicore lesions - MYOPMIL |  | * Myopathy, congenital with respitory insufficiency and bone fractures - MYORIBF |
|
Myopathy, congenital, progressive with scoliosis - (AR) | 3.61 | | |  | * Myopathy, congenital, progressive with scoliosis - MYOSCO |
|
Congenital Myopathy related to SCN4A - (AR) | 3.62 | | | Sodium channel, voltage-gated, type IV, alpha
|
|
|  | * Hyperkalemic periodic paralysis - HYPP |  | * Myotonia potassium-aggravatd | | * Sodium-channel myasthenia |  | * Myasthenic syndrome, acetazolamide-responsive |  | * Myasthenic syndrome, congenital, 16 - CMS16 | | * Severe foetal hypokinesia related to SCN4A |  | * Hyperkalemic periodic paralysis, type 2 - HOKPP2 |  | * Paramyotonia congenita of Von Eulenburg - PMC |  | * Potassium-aggravated myotonia |
|
Congenital Myopathy related to PYROXD1 - (AR) | 3.63 | | | Pyridine nucleotidedisulphide oxidoreductase domain 1
|
|
| | * Early-onset myofibrillar myopathy with PYRODX1 defect | | * LGMD related to PYROXD1 | | * Congenital Myopathy related to PYROXD1 |
|
Congenital Myopathy related to TNPO3 - (AD) | 3.64 | | |  | * Muscular dystrophy, Limb-Girdle, Type 1F - LGMD1F | | * Congenital Myopathy related to TNPO3 |
|
Scapuloperoneal myopathy, MYH7-related - (AD) | 3.65 | | | Myosin, heavy polypeptide 7, cardiac muscle, beta
|
|
|  | * Cardiomyopathy, dilated, 1S - CMD1S |  | * Myopathy, distal 1 - MPD1 |  | * cardiomyopathy, familial hypertrophic, 1, included - CMH1 |  | * Left ventricular noncompaction 5 - LVNC5 |  | * Myopathy, myosin storage, autosomal dominant - MSMB |  | * Myosin storage myopathy |
|
Dusty core disease related to RYR1 - (AR) | 3.66 | | | Ryanodine receptor 1 (skeletal)
|
|
|  | * centronuclear myopathy, recessive |  | * minicore myopathy with external ophthalmoplegia | | * myopathy, congenital, with fiber-type disproportion - CFTD | | * Fetal akinesia deformation sequence related to RYR1 |  | * Dusty core disease related to RYR1 - DuCD |  | * Malignant hyperthermia susceptibility 1 - MHS1 |  | * Central core disease - CCD |
|
Lysosomal storage myopathy - (AR) | 3.67 | | |  | * Lysosomal storage myopathy - ML4 |
|
Congenital myopathy - (AD) | 3.68 | | | |